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Bone crystallite chemistry and structure change during bone maturation.
However, these properties of bone can also be affected by limited uptake of the
chemical constituents of the mineral by the animal. This makes probing the
effect of bone-mineralization-related diseases a complicated task. Here it is
shown that the combination of vibrational spectroscopy with two-dimensional
X-ray diffraction can provide unparalleled information on the changes in bone
chemistry and structure associated with different bone pathologies (phosphate
deficiency) and/or health conditions (pregnancy, lactation). Using a synergistic
analytical approach, it was possible to trace the effect that changes in the
remodelling regime have on the bone mineral chemistry and structure in normal
and mineral-deficient (hypophosphatemic) mice. The results indicate that
hypophosphatemic mice have increased bone remodelling, increased carbonate
content and decreased crystallinity of the bone mineral, as well as increased
misalignment of crystallites within the bone tissue. Pregnant and lactating mice
that are normal and hypophosphatemic showed changes in the chemistry and
misalignment of the apatite crystals that can be related to changes in
remodelling rates associated with different calcium demand during pregnancy
and lactation.
1. Introduction
Bone is a complex inorganic–organic hybrid material,
comprising nano-sized carbonate apatite crystals mineralizing
a collagen matrix. It serves multiple functions within the body,
including structural support for our locomotive system and as
an ion reservoir for homeostasis (Glimcher, 2006). However,
bone metabolic diseases and/or malnutrition can disrupt the
ability of the organism to mineralize the collagen matrix,
causing skeletal malformations such as rickets or osteoporosis.
Severe genetic diseases such as X-linked hypophosphatemia
(XLH) are characterized by increased activity of the enzyme
alkaline phosphatase and increased renal phosphate wasting,
resulting in poor bone-matrix mineralization (Carpenter et al.,
2011). Lower Ca, and specifically phosphate, absorption in
mice with a phenotype of XLH (HYPmice) has been shown to
correlate with higher carbonate content in the bone (Macica et
al., 2016) and dentine (Amenta et al., 2018) minerals. These
changes become more evident in bone during conditions of
high calcium demand, such as pregnancy or lactation, during
which bone remodelling increases to meet increasing calcium
demand (Macica et al., 2016).
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Increasing the carbonate content of bone apatite crystals is
expected to have consequences for their physical properties
and functionality. For example, carbonate incorporation into
synthetic hydroxyapatites has been shown to decrease the
crystallinity (McElderry et al., 2013) and thus stability of the
mineral phase (Rollin-Martinet et al., 2013). In addition,
higher carbonate contents have been shown to increase
resorption by osteoclast cells (Nakamura et al., 2016). There-
fore, probing the consequences of changes in bone mineral
chemistry is an important area of research to understand the
impact of altered mineralization on bone functionality.
However, bone mineralization is a complex process that has
been shown to occur in two stages, where fast mineralization
of up to 75% of the final mineral content in bone occurs
initially (primary mineralization), followed by a slower
secondary mineralization step (Busa et al., 2005; Bala et al.,
2010; Boivin & Meunier, 2002). Secondary mineralization
creates highly oriented crystals aligned with the collagen
fibres. Therefore, newly deposited bone mineral is expected to
be poorly organized with nearly random crystal orientations
compared with more mature bone tissue with a higher degree
of crystal alignment (Ishimoto et al., 2013). Similarly, the bone
crystals themselves undergo chemical and structural modifi-
cation during maturation (Glimcher, 1998). In normal bone,
mineral maturation is associated with an increase in crystal-
linity, but also with a concomitant increase in carbonate
substitution (Combes et al., 2016). Thus, deconvoluting the
effects of maturation and inhibited mineralization is not
trivial. Identifying mature and immature bone and linking this
to changes in chemistry and structure on the mineral and
tissue scale requires the physical separation of mineral frac-
tions (Rey et al., 2009) or a synergistic approach of comple-
mentary techniques that probe these fractions independently.
X-ray diffraction (XRD) and vibrational spectroscopy
(Raman and IR) are routinely used in the analysis of bone to
study its crystallinity (Bonar et al., 1983; Kuhn et al., 2008) and
chemical changes (Penel et al., 1998; Awonusi et al., 2007;
Cazalbou et al., 2004; Rey et al., 1989; Macica et al., 2016),
respectively. This includes studying changes in chemistry or
crystallinity associated with bone mineralization disorders; see
Boskey (2002) for a short review. However, these techniques
also produce complimentary information about structural
ordering within the crystallites (Querido et al., 2018; London˜o-
Restrepo et al., 2019), as vibrational spectroscopy is sensitive
to short-range order (Wopenka & Pasteris, 2005), whereas
XRD can be used to examine changes in long-range order
(Bazin et al., 2009). Whilst vibrational spectroscopy can be
conducted on cross-sectioned bone samples, XRD analysis is
typically conducted in powder form, resulting in a loss of
spatial information. In addition, neither vibrational spectro-
scopy nor powder XRD provides information about the
structural properties of the bone tissue itself, which is critical
for evaluating the maturation stage of the bone site investi-
gated. In contrast, two-dimensional XRD (2D-XRD) can be
conducted with no additional sample preparation and on the
same cross sections used for vibrational spectroscopy. This
technique also provides information on the crystallinity of
different bone mineral fractions independently and on the
degree of crystal alignment within the bone tissue (Domin-
guez-Gasca et al., 2019; Rodriguez-Navarro et al., 2018). Here
we test the use of 2D-XRD for studies of bone mineralization
disorders and demonstrate that the combination of vibrational
spectroscopic techniques and 2D-XRD analysis provides
unparalleled insights into bone properties that are relevant for
these disorders.
2. Experimental details
2.1. Sample preparation
Hypophosphatemic (HYP) and normal wild-type (WT)
mice were used in this study (Table 1 and Fig. 1); see Macica et
al. (2016) for details of the animal rearing and bone sampling.
The experimental conditions, animal age and reproductive age
were selected to provide insights into the effect of metabolic
condition on bone mineral quality. Mice are breast-fed for the
first three weeks of life, so at two weeks of age are still
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Table 1
Descriptions of the mouse samples examined.
WT refers to wild-type mice and HYP denotes mice with a genetic disorder that results in hypophosphatemia.
Sample number† Specimen No. of specimens Age at sacrifice (months) Condition Lactation duration Analytical method
WT_2w_v WT 1 2 weeks Virgin Raman, 2D-XRD
WT_3_v WT 1 3 Virgin IR
HYP_3_l HYP 1 3 Lactating 1 week IR
WT_4_v WT 1 4 Virgin IR, Raman, 2D-XRD
WT_4_l WT 1 4 Lactating 3 weeks IR, 2D-XRD
WT_5_v‡ WT 1 5 Virgin IR, Raman, 2D-XRD
HYP_5_v‡ HYP 1 5 Virgin Raman, 2D-XRD
HYP_5_v2‡ HYP 1 5 Virgin IR, 2D-XRD
WT_5_pn‡ WT 3 5 Pregnant Raman, 2D-XRD
HYP_5_pn‡ HYP 3 5 Pregnant Raman, 2D-XRD
WT_5_l‡ WT 1 5 Lactating 3 weeks Raman, 2D-XRD
HYP_5_l‡ HYP 1 5 Lactating 3 weeks IR, Raman, 2D-XRD
† Sample names indicate the genotype (WTor HYP) followed by the age at sacrifice in months (with the exception of 2w which denotes 2 weeks), the remodelling regime (v = virgin, p =
pregnant, l = lactating) and additional information, where n denotes different numbers related to the multiple samples that were examined and 2w or 3w indicate different lactation
periods of 2 and 3 weeks, respectively. ‡ Samples also studied by Macica et al. (2016).
dependent on maternal milk for all minerals in their diet.
During this stage HYP mice do not display any metabolic or
skeletal phenotypes associated with hypophosphatemia, as all
mineral demand is met by breast milk. Similarly, all mineral
demand in WT mice is also met by the consumption of breast
milk during this phase. At five months of age, the mice are
skeletally mature and the HYP mice display the effects of
hypophosphatemia. Thus, five-month-old mice were selected
so that the effects of increased mineral demand, through
pregnancy and lactation, on mineral quality could be exam-
ined. Virgin HYP mice sacrificed at five months of age were
used as a baseline for mineral quality. Mineralization of
foetuses is highest during late pregnancy (E10–E18.5), there-
fore by sacrificing the mice at the end of pregnancy (day of
giving birth, E18.5) maternal mineral demand is captured in
the pregnant mouse specimens. Similarly, the lactating speci-
mens were shown to display the bone remodelling and
hormonal balance effects of lactation at 21 days after giving
birth.
The mice were reared in accordance with the Guide for the
Care and Use of Laboratory Animals recommendations, and
the procedural protocol was approved by Yale’s Institutional
Animal Care and Use Committee.
A longitudinal cross section of the right tibia and fibula
bones embedded in a (poly)methyl methacrylate (PMMA)
matrix was used for Raman spectroscopic and 2D-XRD
analyses. For Fourier transform infra-red (FT–IR) analysis,
left femoral diaphyses were embedded and microtomed to
produce longitudinal thin sections of 4 mm thickness.
2.2. X-ray diffraction analysis
Whole bone samples were analysed in transmission mode
with an X-ray single-crystal diffractometer (D8 VENTURE,
research papers
962 Helen E. King et al.  Bone mineralization probed by spectroscopy and XRD J. Appl. Cryst. (2019). 52, 960–971
Figure 1
(a) The sampling areas for Raman and XRD analysis, showing a comparison of wild-type (WT) and hypophosphatemic (HYP) mouse tibia and fibula
longitudinal cross sections embedded in (poly)methyl methacrylate blocks. The tibia are highlighted by dashed lines. (b) A schematic diagram of the tibia
and fibula, showing the approximate positions of the Raman maps (stars) and 2D-XRD analysis (dashed circle). (c) A light microscopy image of a typical
Raman map site (star) from a midshaft site on an HYP mouse bone. (d) A typical fit of a Raman spectrum taken from a WT mouse bone sample.
Bruker) equipped with a PHOTON 100 area detector and Mo
microsource (50 kV and 1 mA, wavelength 0.71 A˚; 0.1 mm
collimator). Apatite crystals in cortical bone generally show a
preferential orientation with their c axes aligned parallel to
the elongation axis of long bones (Weiner & Wagner, 1998),
visible as two arcs in the Debye–Scherrer ring [Fig. 2(a)]. A
quantitative estimate of the degree of alignment of the crys-
tals’ c axes was determined from the angular breadth of bands
displayed in the intensity profile along the Debye–Scherrer
ring ( scan) for the 002 reflection of apatite (Wenk &
Heidelbach, 1999). A narrower band indicates a higher degree
of crystal alignment. The intensity below the two bands
corresponds to randomly oriented crystals contributing as a
continuous ring to the 2D-XRD patterns [Fig. 2(c)]. The
fraction of oriented bone crystals (FOBC) can be estimated as
Ioriented/(Ioriented + Irandom), where Ioriented is the 002 intensity of
the bands and Irandom is the intensity of the continuous ring
(Dominguez-Gasca et al., 2019).
Data reduction including centring and 2 and  scan
generation was performed using the XRD2DScan software
(Version 4.1.1; Rodriguez-Navarro, 2006). The peaks in the 2
scans and bands in the  scans were fitted in Fityk (Wojdyr,
2010) using a Gaussian function. Additionally, crystallinity was
determined by measuring the FWHM of the 002 and 310 peaks
displayed in the 2 scans [Fig. 2(b)] using the Scherrer equa-
tion to calculate the crystallite domain size for each reflection
(thkl) (Langford & Wilson, 1978):
thkl ¼
K
B cos 
; ð1Þ
where B is the FWHM of the peak in radians. K was estimated
to be 2.0 (Ziv & Weiner, 1994).
Standard carbonated apatite powder samples were exam-
ined under a microscope and mounted with oil on a MiTeGen
mount, then transferred onto an AFC11 goniometer. Room-
temperature diffraction data (Fig. S1 in the supporting infor-
mation) were collected with a Rigaku MicroMax-007HF
source (Cu K;  = 1.54178 A˚) coupled to a Saturn994+ CCD
detector. Line profiles of the 2D diffraction data were inte-
grated and processed with the Rigaku 2DP software package.
2.3. Vibrational spectroscopy analysis
AHoriba HR800 Raman microspectrometer equipped with
a 532 nm laser and 100 objective lens was used to examine
spatially resolved areas of cortical bone (Fig. 1). To reduce the
spectral background and prevent sample burning, the laser
power was lowered by 1000 using an optical density filter
prior to interaction with the sample. The laser beam spot size
with the 100 objective lens is 1 mm. For spectrum acqui-
sition, a confocal hole size of 300 mm was used with an
1800 grooves mm1 grating and 50 mm slit width.
Four map grids of 4  4 spot analyses at a step size of 3 mm
were obtained for each sample. Each map area was chosen to
lie between osteocytes and to avoid the unmineralized areas
reported within HYP mouse cortical bone (Macica et al.,
2016). Each spectrum was collected for 30 s and integrated ten
times to obtain adequate signal-to-noise ratios for data
analysis. An estimate of the contribution from the PMMA
embedding material was calculated from the relative band
heights in pure PMMA surrounding the bones. The synthetic
standards of B-site-substituted carbonated hydroxyapatite
used for carbonate calibration were Biorad hydroxyapatite
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Figure 2
(a) A representative 2D-XRD pattern generated from an orientated
pregnant WT mouse bone sample. Arcs displayed in the 002 ring show
that the crystal c axes are aligned with the long axis of the bone. (b) A 2
scan generated from an angular sector in the 2D-XRD pattern containing
the intense 002 arc. The large peak beginning at 5 is related to the
(poly)methyl methacrylate (PMMA) block that the bone was embedded
in. No background removal has been conducted on either of the patterns.
(c) A 002  scan showing the contribution of the oriented and non-
oriented fractions of bone mineral.
and previously analysed samples (Yoder et al., 2012). Each of
the seven standard samples was in powder form and three
spectra were collected within each sample.
Bands from the bone and synthetic samples were fitted on
the basis of the band assignments from previous studies
(Awonusi et al., 2007; Pasteris & Ding, 2009). Prior to calcu-
lating the carbonate content from the Raman spectra the
PMMA contribution to the spectra was subtracted. First the
background in both the PMMA and bone spectra was
removed using a linear function in Labspec 5 (Horiba Scien-
tific). The contribution from the PMMAwas then estimated by
normalizing the band intensity at 813 cm1 in the bone
spectra, the most intense PMMA band in the region of interest
(Fig. S2), with that of the pure PMMA spectrum. Finally, the
PMMA spectrum was subtracted from the bone spectra using
the spectral correction tool also available in LabSpec 5. In the
analysed samples, some spectra showed evidence for excessive
PMMA contribution, which swamped the bone-related spec-
tral bands. These spectra were not used for data analysis.
All of the mouse sample sites analysed using Raman spec-
troscopy produced spectra with the same band locations
within the spectral resolution of the Raman instrument, with
slight variations in relative intensities. As documented in other
studies (McElderry et al., 2013; Penel et al., 1998), the phos-
phate 1 stretching band was asymmetrical in shape with a
shoulder at lower wavenumbers. Therefore, the best fit was
found when a band with a centre at 960 cm1 and a second
smaller shoulder band close to 950 cm1 were used in the
fitting procedure. The phosphate 3 region between 1010 and
1050 cm1 was fitted using two bands, one close to 1025 cm1
and a second close to 1045 cm1 [Fig. 1(d)]. The smaller band
at 1010 cm1 reported in other studies and observed in the
synthetic samples was often swamped by the larger 1003 cm1
band, resulting in minimal to no contribution detectable for
this band in the mouse spectra during our band-fitting
procedure. In previous studies the band at 1003 cm1 has been
attributed to HPO4 sites in the bioapatite crystals that can
charge compensate for the inclusion of the carbonate group
(Penel et al., 1998). However, Raman spectra taken for virgin
mice that were terminated at two weeks show that an
increased intensity in the 1003 cm1 band correlates with the
increased intensity in bands throughout the spectral region of
interest that are associated with collagen molecules (Fig. 1).
This is in keeping with the expected lower mineralization of
the still-developing mouse at two weeks and the attribution of
this band to phenylalanine groups (Frushour & Koenig, 1975)
of collagen by Pasteris & Ding (2009). Therefore, we examine
the contribution of the 1003 cm1 band as a ratio with the
phosphate to examine changes in collagen and HPO4 content.
The carbonate contribution produces bands at 1100 and
1070 cm1, depending on whether the carbonate is substituted
for an OH (A-type) or phosphate (B-type) within the hy-
droxyapatite crystal structure, respectively (Penel et al., 1998).
This previous work demonstrated that bone contains both A-
and B-type substitutions. The carbonate contribution was
calculated as described in detail by Awonusi et al. (2007) with
the inclusion of the A-type carbonate contributions using the
ratio between the areas of the carbonate and phosphate 1
stretching bands at 1070 (B-type) and 1100 cm1 (A-type) and
960 (B-type) and 950 cm1 (A-type), respectively.
The presence of collagen bands can have important
consequences for further analysis of carbonate content and
crystallinity, where underlying collagen bands may alter the
shape and intensity of the mineral-related bands. However,
the two-week-old WT mouse shows the largest contribution of
the 1003 cm1 band, as can be observed from the spectrum
(Fig. S3), but one of the lowest calculated overall carbonate
contents. Therefore, the effect of underlying collagen spectra
on the crystallinity and carbonate calculation is expected to be
minimal.
Errors corresponding to fitting of the spectra were esti-
mated by independently assigning band positions and fitting
the spectral region of interest six times. This error was much
smaller than the deviation associated with measuring different
locations in the bone. Thus, the error associated with calcu-
lation of mean values was taken from the standard deviations
(s.d.s) across the mapped regions. The synthetic standards’
spectra were fitted using six bands at 948, 960, 1010, 1025, 1045
and 1070 cm1, as described by Awonusi et al. (2007). No
evidence for A-site substitution of carbonate was found in the
synthetic material. Errors in the carbonate content of the
mouse specimens were calculated using the s.d.s of the average
measurements and the standard error of the slope and inter-
cept generated from linear regression of the calibration plot
[Fig. S1(c)].
For FT–IR analysis, a synchrotron-based FT–IR micro-
spectroscope with FT–IR imaging was used at Brookhaven
National Laboratory National Synchrotron Light Source on
beamline U10B. A spectrophotometer, with a Hyperion IR
microscope (Bruker, Bilerica, USA) with a mercury cadmium
telluride detector, was used in the frequency range 4000–
650 cm1 via spectral mapping. Spectra were collected at 128
scans per point in transmission mode. Background spectra
were collected through an empty specimen holder. Four
64  64 mm regions of interest were analysed on the bone
samples. Data were collected and processed using the Opus
software (Bruker, Bilerica, USA). See Acerbo et al. (2012) and
references therein for further details of the experimental
setup.
Prior to band fitting, the PMMA-related background was
removed using the Opus software. To quantify the contribu-
tion of the PMMA, a spectrum of the PMMA embedding
material alone was taken. PMMA has major absorption
features that overlap with the protein, carbonate and mineral
phosphate bands found in bone, and is most easily recognized
by a unique and intense carbonyl ester absorption band
centred at 1745 cm1 (Acerbo et al., 2012). As described by
Acerbo et al. (2012), the mineral-to-collagen ratio was calcu-
lated using the intensity of IR bands between 1600 and
1700 cm1 (amide I band) related to the collagen, and the
intensity of the phosphate symmetrical stretching bands
between 900 and 1200 cm1. The overall carbonate-to-
phosphate ratio was calculated using the carbonate (1414–
1424 cm1) and phosphate (900–1200 cm1) bands.
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2.4. Statistical analysis
Basic descriptive statistics were used to characterize the
bone properties. Pearson’s correlation analysis and linear
regression models were used to study the relationships
between the different properties of bone. One-way and two-
way analysis of variance (ANOVA) tests were used to deter-
mine differences among groups for all determined bone
compositional and structural variables. In the case of spectral
maps, points were considered independent replicates. The
standard deviations of variables were used to depict the errors
of the measurements. Differences among variables were
considered significant at p < 0.05. All statistical analyses were
performed using the Origin Pro (Microcal) software package.
3. Results
3.1. Bone mineral characteristics and their relationship to
mouse age
The X-ray diffraction data from tibiae cortical bone show
that there are significant changes in the crystallinity and
structural organization (crystal orientation) of bone crystals
with age, genotype and health status of the mice. For instance,
in the control group (WT virgin), the youngest mouse sample
(WT_2w_v) showed the smallest FOBC, which correlated with
the greatest degree of crystal misalignment [Figs. 3(a) and
3(b)]. As the age of the mice increased, the FOBC contribu-
tion also increased [Fig. 3(a)]. This is correlated with a
decrease in the angular breadth of the 002 arc, which indicates
that the alignment of the crystals increased with age [Fig. 3(b)].
As observed in the youngest mouse specimen, the FWHM002
for the FOBC in the four- and five-month-old mice showed a
smaller value than the randomly oriented fraction [Fig. 3(c)],
indicating that the FOBCs have a greater crystallinity. The
FWHM310 for the FOBC did not change with age and was
similar to that of the random fraction of the youngest mouse.
This value could not be determined for the four- or five-
month-old mice as the intensity was too low.
Crystallinity was also evaluated using the FWHM of the
symmetrical stretching band for phosphate at 960 cm1, the
most intense Raman band (see e.g. Fig. 1). The largest
FWHM960 of the virgin WT mouse samples was found in the
youngest mouse sample (16.05, s.d. 0.07 cm1). In addition to a
lower crystallinity, the Raman spectroscopy measurements of
the youngest mouse also displayed a higher contribution of
collagen to the spectra [Fig. 3(d)], measurable using the
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Figure 3
Changes in mineral characteristics related to age in WTmice. (a) The fraction of orientated bone crystals calculated using the 2D-XRD 002 ring intensity
associated with oriented and random crystals for the two-week and four- or five-month-old WTmice. (b) The degree of crystal alignment measured using
the change in 002 arc angular breadth. (c) The FWHMmeasured for oriented and random crystal populations using the 002 and 310 reflections in the 1D-
XRD patterns. Error bars show the variation expected in the values based on multiple measurements of different pregnant mouse specimens. (d)
Mineral-to-collagen versus carbonate-to-phosphate ratios obtained from individual Raman mapped areas in the three WT mouse specimens at different
ages.
phosphate-to-1003 cm1 ratio (Fig. S3). This is supported by
the higher intensities of other collagen bands (Frushour &
Koenig, 1975). Virgin mice analysed with FT–IR that were
sacrificed at four (WT_4_v) and six months (WT_6_v) also had
a higher mineral content (Table 2). The virgin mouse sacrificed
at five months (WT_5_v) did not appear to follow this trend,
with its mineral content slightly lower than the mouse sacri-
ficed at four months. Analysis of the carbonate content and
phosphate-to-collagen ratio from the FT–IR data for these
specimens showed a homogeneous distribution [Fig. 4(a)].
This correlates with the low standard deviation obtained for
these ratios using Raman spectroscopy, indicating that the
femur and tibia are similar in our samples. Virgin WT mice
show an increase in the carbonate ratio with age, from 0.163,
s.d. 0.003, in the two-week-old mouse to 0.204, s.d. 0.005, in
four-month-old and 0.221, s.d. 0.004, in five-month-old virgin
mice measured using Raman spectroscopy. However, this
effect is not visible in the FT–IR data (Table 2). Changes in
crystallinity determined spectroscopically are correlated with
changes in the carbonate content. Virgin WT mice show a
homogeneous distribution of carbonate content and phos-
phate-to-collagen ratio when they have reached five months,
as shown in the FT–IR maps in Fig. 4.
3.2. Effect of different health conditions on bone mineral
characteristics
Bone mineral in pregnant and especially lactating mice had
a smaller FOBC compared with virgin mice [Fig. 5(a)]. As
observed with the age-related samples, a decrease in the
FOBC is coupled with an increase in the angular breadth of
the 002 arcs, indicating an increase in the misalignment of the
crystals [Fig. 5(b)]. In general, we observed the following trend
of decreasing FOBC and crystal orientation: virgin >
pregnant > lactating. The FWHM002 displayed no change for
the FOBC between the five-month-old virgin, pregnant and
lactating WT mice. However, in the pregnant and lactating
WT mice there was a large decrease in the FWHM of
randomly oriented crystals [Fig. 5(c)], implying a diffracting
domain size that is similar to that found in the FOBC. There
was also a decrease in the FWHM310 in the FOBC in the
pregnant and lactating WTmice. Again, crystallinity decreases
according to the following sequence: virgin > pregnant >
lactating.
The Raman spectroscopy data show that the phosphate-to-
1003 cm1 ratios increased from 10.7, s.d. 0.2, in the virgin
mouse to 29.1, s.d. 0.6, in the pregnant mice, before returning
to lower ratios of 14.1, s.d. 0.6, in the lactating mouse. This is
consistent with the FT–IR data, which showed almost no
change between the collagen content of the virgin WT and
lactating WT mice (Table 2). Despite the increase in
diffracting domain size, indicating an increase in long-range
crystallinity, the Raman spectroscopy FWHM960 measure-
ments suggested that short-range crystallinity decreased for
the pregnant (15.70, s.d. 0.03 cm1) and lactating (15.52, s.d.
0.04 cm1) mice compared with the virgin mouse (15.42, s.d.
0.04 cm1). No change in the carbonate content was detected
in the vibrational spectroscopy analyses related to remodelling
regime.
3.3. Evidence for mineral changes due to hypophosphatemia
The X-ray diffraction data show that bone mineral in the
virgin HYP mouse had a smaller FOBC than that in the virgin
WT mouse [Fig. 5(a)]. Also, there is, as expected, an increase
in the angular breadth of the 002 arc [Fig. 5(b)]. The FWHM002
for the FOBC did not differ between WT and HYP mice.
However, the FWHM002 for the randomly oriented fraction in
HYP mice was smaller than that for the virgin WT mice
[Fig. 5(c)], indicating that the crystals had larger domains
along the c axis in the virgin HYP mouse. Similarly, values of
the FWHM310 were smaller in the HYP virgin mouse. The
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Table 2
Carbonate-to-phosphate and mineral-to-collagen ratios calculated from
the averages from the individual FT–IR spectra within the mapped areas.
Errors are the standard deviation (1) of the data.
Sample Carbonate/phosphate Mineral/collagen
WT_3_v 0.021  0.003 5.2  0.7
HYP_3_l 0.027  0.004 4.4  0.6
WT_4_v 0.022  0.004 6.0  0.6
WT_4_l2w 0.022  0.004 4.9  0.9
WT_5_v 0.024  0.001 5.6  0.7
HYP_5_v2 0.028  0.004 4.9  0.9
HYP_5_l 0.030  0.002 4.2  0.8
Figure 4
FT–IR transmission maps of femoral bones from (a), (b) virgin WT
mouse femoral bones and (c), (d) virgin HYP mice. Panels (a) and (c)
show the mineral-to-collagen ratio measured using the collagen 1600–
1700 cm1 bands and the phosphate bands spanning 900–1200 cm1,
respectively. Panels (b) and (d) show the variability in carbonate content
of the bone mineral phase using the carbonate and phosphate spectral
bands spanning 1414–1424 and 900–1200 cm1, respectively. Each map is
100  120 mm.
crystallinity obtained from Raman spectroscopic analysis was
in agreement with the 2D-XRD data, where the FWHM960 of
the virgin HYP mouse (16.06, s.d. 0.06) was higher than that of
the virgin WT mouse (15.42, s.d. 0.04). The virgin HYP mouse
also showed a higher variability of its phosphate-to-collagen
ratio compared with the virgin WT mouse, as can be observed
by comparing Figs. 4(a) and 4(c). This is reflected in the
Raman spectroscopy data and standard deviation, which
showed an increase in the phosphate-to-1003 cm1 ratio from
10.7, s.d. 0.2, in the virgin WT mouse to 12.6, s.d. 0.7, in the
virgin HYP mouse. The FT–IR map demonstrated that the
carbonate content within the virgin HYP mouse bone sections
had a higher variability than those from virgin WT mice [c.f.
Figs. 4(b) and 4(d)]. A higher average carbonate content for
the virgin HYP mouse compared with the virgin WT mice was
also determined from Raman spectroscopic measurements,
where the virgin HYP mouse had a carbonate-to-phosphate
ratio of 0.26, s.d. 0.01, whereas the virgin WT mouse had a
ratio of 0.221, s.d. 0.004.
For HYP mice, the lactating HYP mouse showed the
greatest crystal misalignment [Fig. 5(b)]. The pregnant HYP
mouse measurements did not follow the expected trend
observed in the WT mice for FOBC: virgin > pregnant >
lactating. Instead, the pregnant HYP mice have a similar to
slightly elevated FOBC and slightly lower 002 angular breadth
compared with the virgin HYP mouse. As observed in the WT
mice, the lactating HYP mouse FWHM002 measurement was
the same for both the randomly oriented and oriented frac-
tion. Unlike the WT mice, however, the FWHM of the 310
reflection showed no difference from that of the HYP virgin
mouse, indicating that no change in domain size of 310
occurred in relation to remodelling during lactation. The
unusual behaviour of the angular breadth and oriented frac-
tion in pregnant HYP mice was mirrored by an increase in the
FWHM002 of the randomly oriented fraction. The FWHM310
of the FOBC displayed similar values independent of the
health status (pregnant, lactating) or remodelling regime in
the HYP mice.
Regarding the Raman data, the lactating HYP mouse
showed the highest FWHM960 measured in this study (16.59,
s.d. 0.13), consistent with the lower long-range crystallinity
determined by 2D-XRD [Fig. 5(c)]. Also, the pregnant HYP
mice show a similar FWHM960 on average to the virgin HYP
mouse in the Raman analysis (16.02, s.d. 0.01, and 16.06, s.d.
0.06, respectively), in agreement with the 2D-XRD data that
there is minimal change in the mineral crystallinity char-
acteristics between the pregnant and virgin HYP mice. Higher
phosphate-to-collagen ratios are observed in the virgin HYP
mouse (HYP_5_v) compared with the lactating HYP mouse
(HYP_5_l) in the FT–IR analysis. The Raman spectroscopy
analysis showed that the phosphate-to-1003 cm1 ratio for the
lactating HYP mouse was the same as that observed in the
pregnant HYP mouse, 25.5, s.d. 2.2, and 25.3, s.d. 1.9, respec-
tively.
The carbonate content in the HYP mice increased following
the sequence virgin (0.26, s.d. 0.01) < pregnant (0.30, s.d.
0.02) < lactating (0.34, s.d. 0.01). These results are consistent
with the FT–IR analysis, which showed a high variability of the
carbonate content within the HYP bones and a higher level in
the lactating mice compared with the virgin HYP mouse. The
amount of substituted carbonate within the mineral phase was
estimated using the regression line shown in Fig. S1. Calcu-
lations of carbonate content showed that the most carbonated
sample, the lactating HYP mouse, had a carbonate content of
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Figure 5
Changes in mineral characteristics due to increased remodelling related
to pregnancy and lactation in WT and HYP mice. (a) The FOBC in the
bone specimens, calculated using the 002 ring intensity associated with
oriented and random crystals. (b) The angular breadth of the 002 arc from
2D-XRD patterns, indicating the degree of crystal alignment with the
long axis of the bone specimen. (c) FWHM measured from the 002 and
310 reflections in the 1D-XRD patterns for oriented and random crystal
populations. Error bars show the variation expected in the values based
on multiple measurements of different pregnant mouse specimens.
8.86 (s.d. 0.01) wt%. In contrast, the lactating WT mouse has a
carbonate content of 5.85 (s.d. 0.01) wt%. These values are
within the ranges observed previously for bovine (Awonusi et
al., 2007) and rabbit (Penel et al., 1998) bones, which have
been shown to contain up to 9 wt% carbonate.
Finally, analysis of variance (two-way ANOVA) was used to
analyse whether the genotypes and health status determine
the observed changes in bone properties. The 2D-XRD data
show that there are significant differences between mouse
genotypes for the FWHM of the 002 reflection of the FOBC
(WT and HYP; p = 0.016) but not among mice with different
health status (p = 0.234). The 002 arc angular breadth showed
no significant differences between mouse genotypes (WT and
HYP; p = 0.50) but here was a significant difference among
mice with different health status (p = 0.027). However, the
FOBC decreases following the same sequence but the differ-
ences are not statistically significant (p = 0.102). The Raman
data show that there are highly significant differences in bone
mineral carbonate content, crystallinity and phosphate-to-
1003 cm1 band ratio between WTand HYP mice (p < 0.001).
Also, there are significant differences for the same parameters
among mice with different health status (virgin, pregnant,
lactating) that represent increasing bone remodelling rate
regimes (p < 0.001). The FT–IR carbonate content only shows
a significant difference between WTand HYP mice (p < 0.001)
but not among the different health status mice analysed
(virgin and lactating; p = 0.695). The degree of mineralization
did not show any significant difference between mice with
different genotypes or health status (p > 0.2).
4. Discussion
4.1. Correlation between degree of bone maturation, mineral
orientation and chemistry
The lower mineral crystallinity and greater disorder indi-
cated in the XRD analysis from the youngest sample
(WT_2w_v) is consistent with newly deposited bone (Ishimoto
et al., 2013), as the rate of bone turnover is expected to be
highest in the youngest mouse (Price et al., 2005). Thus, the
mineral population sampled will have a greater proportion of
less mature mineral crystals (Rey et al., 1991). Similarly, the
increasing values for oriented fraction and alignment of the
four- and five-month-old mice (Fig. 3) fit with bone mineral
maturation as average tissue age increases. The mineral crystal
sizes, as calculated from the XRD measurements (Table S1),
are similar to those documented previously in chicken (Bonar
et al., 1983), bovine (Kuhn et al., 2008) and rat (Turunen et al.,
2011) specimens. Bone mineral shows highly anisotropic peak
broadening for the 002 and 310 reflections as the crystallites
are elongated along the c axis ([001] direction; Fratzl et al.,
2004). In addition, the calculated crystallite sizes are smaller in
the randomly oriented fraction, consistent with less-mature
newly deposited minerals. This is also reflected in the short-
range crystallinity of the mineral phases, measured from the
Raman spectra, which increases with increasing age. Previous
vibrational spectroscopy work on rabbit bones has shown that
younger animals have a lower carbonate content within the
mineral structure of the crystallites (Turunen et al., 2011).
Previous work with FT–IR and WT mice showed the same
trend (Boskey et al., 1998). Our results from Raman spectro-
scopy analysis also show this progression in bone mineral
maturation. Although the structural variations observed with
XRD continued to change above four months of age, the
chemical variations observed in our specimens were minimal.
Bone is an effective store of phosphate and Ca that can be
readily used by the body during times of high demand for
these components (Glimcher, 1998). In normal mice, the
demand for Ca and phosphate for accretion of mineral in the
developing foetus is predominantly compensated for by
increased uptake of these components from food sources. A
decrease in parathyroid hormone (PTH) was observed in the
pregnant WT mice that we studied (Macica et al., 2016), which
is thought to protect the maternal skeleton from remodelling
(Turner et al., 1988). Similarly, increased intestinal uptake is
expected in the normal mice as upregulation of 1,25-di-
hydroxyvitamin D was also observed in the pregnant mice
studied here (Macica et al., 2016). Therefore, limited remo-
delling of the bone is expected in the normal mice. However,
the XRD measurements on the pregnant mice indicate that
the mineral crystal population is not similar to that found in
the virgin mouse as the calculated crystal size increases in the
randomly oriented crystals. Changes in the carbonate content
of the mineral could explain the changes in calculated crystal
size (Zapanta-LeGeros, 1965), but no changes in carbonate
content were observed in the vibrational spectroscopy data. In
the pregnant mice there is evidence for a decrease in the short-
range crystallinity corresponding to an increased phosphate-
to-1003 cm1 ratio. Increased remodelling should produce
lower crystal-to-collagen ratios, and therefore the increased
phosphate-to-1003 cm1 ratio could indicate an increase in the
HPO4 concentrations in the initial mineral phase produced in
the higher remodelling regime in the pregnant mice. This is
consistent with a more immature population being sampled, as
these crystals have been shown to have high HPO4 contents in
rats and bovine samples (Legros et al., 1987). The change in
chemistry indicates that mineral deposition was occurring
during pregnancy in the mouse samples. Indeed, in normal
mouse bone the degree of mineralization can increase by 5–
10% during pregnancy (Sharpe et al., 2003; Woodrow et al.,
2003). However, elevated levels of the type-1 collagen-
degrading enzyme MMP-13 and tartrate-resistant acid phos-
phatase (TRAP) in the pregnant WTmice (Macica et al., 2016)
indicate that resorption is already occurring in these animals,
probably due to the time of sacrifice, which was post partum
and thus the onset of lactation.
Unlike pregnancy, during lactation bone becomes the
dominant source of Ca, where increased bone remodelling can
result in up to 30% mineral loss in normal mice within 21 days
(Sharpe et al., 2003). The largest loss is typically observed in
trabecular bone, but increased levels of MMP-13 in the
cortical bone of the normal mice studied here also suggest
there was increased cortical remodelling (Macica et al.,
2016). Thus, the changes in bone mineral crystal-orientation
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characteristics measured using 2D-XRD can be linked with
higher levels of remodelling in the pregnant and lactating WT
mice. This is consistent with the progressive decrease in the
FOBC from virgin > pregnant > lactating and the concomitant
increase in the angular breadth of the 002 arc. Hence, the
XRD analysis shows that more newly deposited immature
bone mineral populations are present in the lactating mice.
Thus, changes in bone mineral chemistry, crystallinity and
crystal orientation are mainly due to the rate of bone turnover.
4.2. Evidence for changes in bone mineral characteristics due
to hypophosphatemia
HYP mice have been shown to have an impaired uptake of
Ca (Macica et al., 2016) and increased phosphate excretion
(Liang et al., 2009), and hence lower levels of blood serum Ca
and P compared with their WT mouse counterparts (Macica et
al., 2016). In addition to an impaired ability to mineralize
bone, this suggests that the mineralization solution has lower
levels of Ca and P. Evidence for higher levels of bone remo-
delling are also implied in the HYP mouse, as blood serum
levels of PTH are elevated in comparison with normal mice
(Macica et al., 2016). However, HYP mice have decreased
numbers of osteoclasts (Hayashibara et al., 2007) and lower
osteoclast activity (Ono et al., 1996). Higher levels of MMP-13
within the cortical bone of virgin HYP mice, as well as its
association with osteocyte lacunae (Macica et al., 2016),
suggest that alternative forms of bone remodelling through
osteocyte activity may be required to mobilize mineral in these
mice (Wysolmerski, 2012). A higher level of cortical bone
remodelling agrees with our observation of lower FOBC and
alignment in the virgin HYP mouse compared with the virgin
WT mouse at the same age. In the FT–IR maps it can be seen
that the mineral-to-collagen ratios are more heterogeneous in
the virgin HYP mouse throughout the cortical bone in
comparison with the WT mouse. This is also reflected in
observations from HYP mouse bone histology studies, which
show areas of cortical bone with apparent ‘porosity’ in high-
resolution micro-computed tomography images that are
related to unmineralized collagen and a decrease in the
mineral content (Macica et al., 2016).
The carbonate content in the virgin HYP mouse is also
more variable than in the WT mouse, and the overall mineral
carbonate content measured in the FT–IR maps is higher
(Table 2). This is reflected in the Raman spectroscopic
analysis. As the Raman spectroscopy data are expected to
probe the carbonate substituted into the apatite mineral
structure (Penel et al., 1998), while the FT–IR bands probe the
overall mineral carbonate content (both apatitic and non-
apatitic environments) (Combes et al., 2016), the elevation of
carbonate observed with both these techniques indicates that
there is a higher amount of carbonate substitution into the
mineral in the HYP mouse bones. This is the opposite of what
would be expected for higher remodelling rates based on the
Raman spectroscopy findings from the WT_2w_v mouse and
FT–IR analysis from ageing WT mice (Boskey et al., 1998).
Increased carbonate content is associated with a decrease in
the calculated crystallite size for the 310 reflection of
randomly oriented crystals within the virgin HYP mouse and a
decrease in short-range crystallinity observed in the Raman
spectroscopy data. Broadening of the XRD 002 peak with
increasing carbonate content in synthetic hydroxyapatites has
been shown to correlate directly with increases in the solubi-
lity of the mineral phase (Baig et al., 1996). If this trend holds
true for the chemical composition of the HYP mouse bone
crystals, this implies that the mature FOBC should have a
similar solubility to those found in the WT mice. In contrast,
the decrease in the FWHM002 of the HYP mouse randomly
oriented crystal fraction implies that these crystals will have a
lower solubility in comparison with their counterparts in the
WT mouse, despite an apparent increase in carbonate and
decrease in short-range crystallinity.
HYP mice were shown to deploy similar adaptations to
those of WT mice to meet the demands of Ca and P during
pregnancy and lactation. This includes elevation of the levels
of MMP-13 and TRAP (Macica et al., 2016), demonstrating
that these bones have a higher degree of remodelling than the
virgin HYP mouse. In HYP mice this is related to a higher
carbonate content compared with both the virgin HYP mouse
and the WT counterparts. In addition, the 1003 cm1 band in
the pregnant and lactating HYP mice is higher, without a
concomitant decrease in the mineral-to-collagen ratio. This
suggests that, similar to the WT mice, the bone mineral
deposited in HYP mice during pregnancy and lactation also
has a higher HPO4 component. As discussed above, newly
deposited bone mineral is expected to be poorly organized
with random crystal orientations (Ishimoto et al., 2013), but a
similar crystallite alignment was found between the pregnant
and virgin HYP mice, as well as similar crystallinity in both
long- and short-range ordering. Previous observations of bone
mineral maturation (Rey et al., 1991) and synthetic nano-
particles (Cazalbou et al., 2004) show an increase in crystal-
linity and carbonate with time compared with the initially
precipitated material. Thus, the bone mineral measured in the
pregnant HYP mice is expected to be dominated by more
mature crystallites than those observed in the HYP lactating
and virgin mice. In contrast, although cortical bone remodel-
ling appears to remain high in the lactating HYP mouse, the
alignment and short-range order are lowered. Taken together
with the increased carbonate content of the mineral, this
suggests that remineralization of the bone tissue with a higher
carbonate content occurs during lactation, but appears to be
limited during pregnancy.
5. Conclusions
A synergistic approach to characterizing bone that unites 2D-
XRD and vibrational spectroscopy has provided an unpar-
alleled insight into the changes in bone mineral structure and
chemistry associated with changes in the rate of bone re-
modelling and deficient mineralization. Changes in the
remodelling regime produced complicated signatures in the
bone mineral structural organization that can only be un-
ravelled using our approach. The information about unit-cell
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size gained from XRD can be used to clarify potential sources
of changing intensity in the vibrational spectroscopy data. For
example, both the HYP and WT mice show evidence for a
potential increase in the HPO4 content of the bone mineral
during pregnancy and lactation, reflecting the higher rates of
bone turnover observed using other markers (Macica et al.,
2016). The increased osteocyte/MMP-13 activity and increased
bone mineral carbonate content observed previously (Macica
et al., 2016) are also supported by the decrease in crystallinity
and crystal alignment observed in the HYPmice. However, we
could only analyse a small number of samples, so these trends
should be verified with more extensive studies that also
include the orientation of the collagen, e.g. through exam-
ination of the bone samples prior to embedding in epoxy. This
will also allow the mechanical properties of the bone to be
tested, as changes in the mineralization extent and mineral
quality within HYP mouse bones has been linked to increasing
bone fragility (Camacho et al., 1995).
Lower levels of Ca, and particularly of phosphate, in the
HYP mice can be correlated with a clear chemical change in
the bone mineral in our samples, where lower phosphate is
partially compensated by the incorporation of additional
carbonate during mineral growth. The limited sample size
studied here indicates that HYP mice produce bone mineral
with a lower short-range crystallinity consistent with higher
apatitic and non-apatitic carbonate, as well as a higher degree
of crystal misorientation within the bone. Synthetic B-site
carbonated apatites show a higher solubility with increasing
carbonate incorporation (Baig et al., 1996). However, the
XRD measurements from the HYP mice indicate that
increased carbonate in bone, as detected using vibrational
spectroscopy, may not be directly correlated with an increase
in mineral solubility.
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